NCT07026175

Brief Summary

The goal of this clinical trial is to understand how the body responds to short-term, severe low energy availability (LEA) in healthy, weight-bearing endurance athletes aged 18-45 years old. LEA describes a mismatch between an individual's dietary energy intake and the energy cost of their commitments for training and competition. The main questions this trial aims to answer are:

  • Prescribed diet (all food provided)
  • Prescribed running and/or cycling exercise
  • Two visits to ACU Fitzroy campus for blood tests and exercise testing
  • 50 hour stay (two nights and two days) in the ACU metabolic chamber

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Jun 2025Jun 2027

First Submitted

Initial submission to the registry

May 28, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 18, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

2 years

First QC Date

May 28, 2025

Last Update Submit

June 10, 2025

Conditions

Keywords

Relative Energy Deficiency in Sport (REDs)EnduranceAthleteSleeping Metabolic RateProblematic Low Energy Availability

Outcome Measures

Primary Outcomes (1)

  • Sleeping metabolic rate between trials, measured using a human metabolic chamber on night 5 of each trial condition.

    The primary outcome is the within-participant and sex-based difference in Sleeping Metabolic Rate (SMR) across the three trial conditions. Analyses will also compare differences in SMR responses between sexes.

    Night 5 of each trial condition from enrolment to the end of the third trial period.

Other Outcomes (21)

  • Fasting values of metabolic and reproductive hormones between trials.

    Day 1 of each trial condition from enrollment to Day 5 of the third trial period.

  • Overnight pulsatility of luteinising hormone between trials.

    Night 4 of each trial condition from enrolment to Day 5 of the third trial period.

  • Overnight pulsatility of growth hormone between trials.

    Night 4 of each trial condition from enrolment to Day 5 of the third trial period.

  • +18 more other outcomes

Study Arms (3)

Control Trial

NO INTERVENTION

A 6-day control trial. All participants will commence with this trial involving an energy availability of 40 kcal/kg fat-free mass (FFM). Energy intake will be 55 kcal/kg FFM/d and exercise energy expenditure will be 15 kcal/kg FFM/d. This will be followed by a minimum 3-week washout period where the participant will be advised to return to their routine diet and exercise.

Low Energy Availability - Diet

EXPERIMENTAL

A 6-day severe low energy availability (LEA, 15kcal/kg FFM/d) trial, achieved by superimposing restricted energy intake on the HEA trial. Energy intake will be 30 kcal/kg FFM/d and exercise energy expenditure will be 15 kcal/kg FFM/d. This will be followed by a minimum 3-week washout period where the participant will be advised to return to their routine diet and exercise.

Other: Diet-induced low energy availability

Low Energy Availability - Exercise

EXPERIMENTAL

A 6-day severe low energy availability (LEA, 15kcal/kg FFM/d) trial, achieved by superimposing increased exercise energy expenditure on the HEA trial. Energy intake will be 45 kcal/kg FFM/d and exercise energy expenditure will be 30 kcal/kg FFM/d. This will be followed by a minimum 3-week washout period where the participant will be advised to return to their routine diet and exercise.

Other: Exercise-induced low energy availability

Interventions

6-days of severe low energy availability (LEA, 15kcal/kg FFM/d), achieved by superimposing restricted energy intake on the control trial.

Low Energy Availability - Diet

6-days of severe low energy availability (LEA, 15kcal/kg FFM/d), achieved by superimposing increased exercise energy expenditure on the control trial.

Low Energy Availability - Exercise

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Well trained weight-bearing athlete (tier 2-4 1)
  • Perform \~45km per week of weight-bearing endurance training, and able to undertake the prescribed exercise in each trial condition
  • Pass the ESSA pre-exercise screening tool and/or obtain GP clearance to exercise

You may not qualify if:

  • Assessment of red status on the REDs Clinical Assessment Tool
  • Unable to attend ACU in Fitzroy, Victoria, for the 6 study visits for completion of the study protocol
  • Pregnancy
  • Use of hormonal contraceptive with the previous 3 months
  • Onset of peri/menopause

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Australian Catholic University

Fitzroy, Victoria, 3065, Australia

RECRUITING

Related Publications (3)

  • Burke LM, Ackerman KE, Heikura IA, Hackney AC, Stellingwerff T. Mapping the complexities of Relative Energy Deficiency in Sport (REDs): development of a physiological model by a subgroup of the International Olympic Committee (IOC) Consensus on REDs. Br J Sports Med. 2023 Sep;57(17):1098-1108. doi: 10.1136/bjsports-2023-107335.

    PMID: 37752007BACKGROUND
  • Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC, Heikura IA, Melin A, Pensgaard AM, Stellingwerff T, Sundgot-Borgen JK, Torstveit MK, Jacobsen AU, Verhagen E, Budgett R, Engebretsen L, Erdener U. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023 Sep;57(17):1073-1097. doi: 10.1136/bjsports-2023-106994.

    PMID: 37752011BACKGROUND
  • Loucks AB, Kiens B, Wright HH. Energy availability in athletes. J Sports Sci. 2011;29 Suppl 1:S7-15. doi: 10.1080/02640414.2011.588958. Epub 2011 Jul 28.

    PMID: 21793767BACKGROUND

MeSH Terms

Conditions

Relative Energy Deficiency in Sport

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • Louise M Burke, PhD

    Australian Catholic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Louise M Burke, PhD

CONTACT

Margot A Rogers, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: This project employs a nonblinded three-sequence crossover design. All participants will undertake a control trial followed by a counterbalanced allocation to one of the low energy availability (LEA) trials, then they will complete the other low energy availability trial. All trials will have a minimum 3-week washout period between them. Allocation to the LEA trials will be randomised and stratified for sex.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2025

First Posted

June 18, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

June 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The data that support the findings of this study will be available from the corresponding author for a period of 36 months from publication, upon reasonable request for academic use. The data will not be made publicly available, as it contains information that could compromise research participant consent.

Time Frame
For a period of 36 months from publication of the primary outcome.

Locations